ARQT
Arcutis Biotherapeutics, Inc. · Healthcare
Director Howard G. Welgus sold $87K of Arcutis Biotherapeutics, Inc.
Sold$86,541
$8.65Price
10,000Shares
−5%Stake
What ARQT did after the filing
- The stock from Wed, Nov 6 open, $9.37
- +50.6%
- S&P 500, same days
- −0.5%
Measured over 30 trading days, to the Dec 19 close.
Traded Fri, Nov 1. Filed Tue, Nov 5, 4:46 PM ET, after the close. Returns use the Nov 6 open and the Dec 19 close. Not investment advice.